China Regenerative Medicine International Limited (HKG:8158)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Apr 30, 2017
Aesthetic Medical and Beauty Services	64.04M	85.35M	-	-	-
Aesthetic Medical and Beauty Services Growth	-24.97%	-	-	-	-
Medical Services	8.02M	5.26M	-	-	-
Medical Services Growth	52.29%	-	-	-	-
Healthcare Products and Services	-	-	69.49M	41.54M	282.90M
Healthcare Products and Services Growth	-	-	67.29%	-85.32%	55.32%
Total	72.06M	90.62M	69.49M	41.54M	282.90M
Total Growth	-20.48%	30.41%	67.29%	-85.32%	55.32%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Apr 30, 2017
Hong Kong	66.09M	89.93M	68.33M	17.23M	20.69M
Hong Kong Growth	-26.50%	31.62%	296.49%	-16.70%	408.58%
The PRC	5.96M	688.00K	1.16M	24.30M	262.21M
The PRC Growth	766.42%	-40.69%	-95.23%	-90.73%	47.25%
Total	72.06M	90.62M	69.49M	41.54M	282.90M
Total Growth	-20.48%	30.41%	67.29%	-85.32%	55.32%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 24, 2026

Data Sources Report a data error